1871 related articles for article (PubMed ID: 19999646)
1. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
2. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
Frankos VH; Street DA; O'Neill RK
Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
[TBL] [Abstract][Full Text] [Related]
3. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
4. The FDA and drug safety: a proposal for sweeping changes.
Furberg CD; Levin AA; Gross PA; Shapiro RS; Strom BL
Arch Intern Med; 2006 Oct; 166(18):1938-42. PubMed ID: 17030825
[TBL] [Abstract][Full Text] [Related]
5. Cloned animal products in the human food chain: FDA should protect American consumers.
Butler JE
Food Drug Law J; 2009; 64(3):473-501. PubMed ID: 19999640
[TBL] [Abstract][Full Text] [Related]
6. Toys and confectionery--a legally hazardous combination?
Eldred JS; Pape SM
Food Drug Law J; 1998; 53(1):1-8. PubMed ID: 11795326
[TBL] [Abstract][Full Text] [Related]
7. Establishment and maintenance of records under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Dec; 69(236):71561-655. PubMed ID: 15586951
[TBL] [Abstract][Full Text] [Related]
8. Civil and criminal liability associated with food recalls.
Packman JM
Food Drug Law J; 1998; 53(3):437-52. PubMed ID: 10346721
[No Abstract] [Full Text] [Related]
9. Prior notice of imported food under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Nov; 73(217):66293-410. PubMed ID: 19112701
[TBL] [Abstract][Full Text] [Related]
10. Marketing nutrition & health-related benefits of food & beverage products: enforcement, litigation & liability issues.
Roller S; Pippins R
Food Drug Law J; 2010; 65(3):447-69, i. PubMed ID: 24479235
[TBL] [Abstract][Full Text] [Related]
11. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
12. Medical device safety: FDA's postmarket transformation initiative.
Schultz D
Food Drug Law J; 2007; 62(3):593-6. PubMed ID: 17915401
[No Abstract] [Full Text] [Related]
13. The importance of GRAS to the functional food and nutraceutical industries.
Burdock GA; Carabin IG; Griffiths JC
Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
[TBL] [Abstract][Full Text] [Related]
14. Reviving the FDA's Authority to Publicly Explain Why New Drug Applications Are Approved or Rejected.
Herder M
JAMA Intern Med; 2018 Aug; 178(8):1013-1014. PubMed ID: 29971404
[No Abstract] [Full Text] [Related]
15. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
Alder HC
Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
[TBL] [Abstract][Full Text] [Related]
16. Title III of the Bioterrorism Act: sacrificing U.S. trade relations in the name of food security.
Boisen CS
Am Univ Law Rev; 2007 Jan; 56(3):667-718. PubMed ID: 17312612
[No Abstract] [Full Text] [Related]
17. The Safe Medical Devices Act of 1990--FDA. Notice.
Fed Regist; 1991 Apr; 56(66):14111-3. PubMed ID: 10111151
[TBL] [Abstract][Full Text] [Related]
18. Should preemption apply in a pharmaceutical context? An analysis of the preemption debate and what regulatory compliance statutes contribute to the discussion.
Surprenant JA
Fordham Law Rev; 2008 Oct; 77(1):327-63. PubMed ID: 18982554
[TBL] [Abstract][Full Text] [Related]
19. Dietary supplement adverse event reports: review and analysis.
Talati AR; Gurnani AK
Food Drug Law J; 2009; 64(3):503-13. PubMed ID: 19999641
[TBL] [Abstract][Full Text] [Related]
20. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
